Auto-disable Syringes Market by Indication, Application, End-User

Description

List of Tables

[199 Pages Report] The Auto-disable Syringes Market size was estimated at USD 23.28 billion in 2023 and expected to reach USD 25.94 billion in 2024, at a CAGR 11.54% to reach USD 50.01 billion by 2030.

Global Auto-disable Syringes Market

KEY MARKET STATISTICS
Base Year [2023]	USD 23.28 billion
Estimated Year [2024]	USD 25.94 billion
Forecast Year [2030]	USD 50.01 billion
CAGR (%)	11.54%

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Auto-disable Syringes Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Auto-disable Syringes Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Auto-disable Syringes Market, highlighting leading vendors and their innovative profiles. These include AccuPoint by AdvaCare Pharma, Al Shifa Medical Products Co., Apple Syringe, Becton Dickinson & Company, Duopross Meditech Corp., Hindustan Syringes & Medical Devices Ltd, Hunan Pingan Medical Device Technology Co., Ltd. by Winner Medical Co., Injecto A/S, Iscon Surgicals Ltd., JMI SYRINGES & MEDICAL DEVICES LTD., Merck KGaA, PT Oneject Indonesia, Retractable Technologies, Inc., Sanavita Pharmaceuticals GmbH, Shandong Zhushi Pharmaceutical Group Co.,Ltd., Shanghai Kohope Medical Devices Co., Ltd., Shenzhen Medis Medical, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Auto-disable Syringes Market to forecast the revenues and analyze trends in each of the following sub-markets:

Indication
- Infectious Diseases
- Inflammatory/Auto-Immune Diseases
Application
- Blood Collection
- Drug Delivery
- Vaccination
End-User
- Ambulatory Surgical Centers
- Diagnostic Laboratories
- Hospitals
Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Auto-disable Syringes Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Auto-disable Syringes Market?

3. What are the technology trends and regulatory frameworks in the Auto-disable Syringes Market?

4. What is the market share of the leading vendors in the Auto-disable Syringes Market?

5. Which modes and strategic moves are suitable for entering the Auto-disable Syringes Market?

Product Code: MRR-D86B4AA1ED24

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Auto-disable Syringes Market, by Region

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising incidence of needle stick injuries and cross infection
  - 5.1.1.2. Significant preference of healthcare organizations towards the use of auto-disable syringes
  - 5.1.1.3. Increasing demand for immunization coverage
- 5.1.2. Restraints
  - 5.1.2.1. High cost of procurement and raw material
- 5.1.3. Opportunities
  - 5.1.3.1. Increasing scope in mass application campaign
  - 5.1.3.2. Ongoing advancements in auto-disable syringes
- 5.1.4. Challenges
  - 5.1.4.1. Concern regarding unsafe injection practices and logistic challenges
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Auto-disable Syringes Market, by Indication

6.1. Introduction
6.2. Infectious Diseases
6.3. Inflammatory/Auto-Immune Diseases

7. Auto-disable Syringes Market, by Application

7.1. Introduction
7.2. Blood Collection
7.3. Drug Delivery
7.4. Vaccination

8. Auto-disable Syringes Market, by End-User

8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Diagnostic Laboratories
8.4. Hospitals

9. Americas Auto-disable Syringes Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Auto-disable Syringes Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Auto-disable Syringes Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

13.1. Key Company Profiles
- 13.1.1. AccuPoint by AdvaCare Pharma
- 13.1.2. Al Shifa Medical Products Co.
- 13.1.3. Apple Syringe
- 13.1.4. Becton Dickinson & Company
- 13.1.5. Duopross Meditech Corp.
- 13.1.6. Hindustan Syringes & Medical Devices Ltd
- 13.1.7. Hunan Pingan Medical Device Technology Co., Ltd. by Winner Medical Co.
- 13.1.8. Injecto A/S
- 13.1.9. Iscon Surgicals Ltd.
- 13.1.10. JMI SYRINGES & MEDICAL DEVICES LTD.
- 13.1.11. Merck KGaA
- 13.1.12. PT Oneject Indonesia
- 13.1.13. Retractable Technologies, Inc.
- 13.1.14. Sanavita Pharmaceuticals GmbH
- 13.1.15. Shandong Zhushi Pharmaceutical Group Co.,Ltd.
- 13.1.16. Shanghai Kohope Medical Devices Co., Ltd.
- 13.1.17. Shenzhen Medis Medical
- 13.1.18. Terumo Corporation
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing